NPI: 1093776734 · KANSAS CITY, MO 64108 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/31/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/31/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,590 | $527K |
| 2019 | 12,112 | $433K |
| 2020 | 15,204 | $417K |
| 2021 | 11,917 | $487K |
| 2022 | 9,472 | $459K |
| 2023 | 6,430 | $341K |
| 2024 | 5,258 | $315K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 52,766 | 4,358 | $2.98M |
| J3490 | Unclassified drugs | 759 | 52 | $197.78 |
| 82728 | 821 | 604 | $0.00 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 4,581 | 256 | $0.00 |
| 83550 | 811 | 605 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 825 | 661 | $0.00 |
| 82746 | 58 | 43 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,172 | 622 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 51 | 39 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 191 | 120 | $0.00 |
| 82607 | 40 | 30 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 38 | 33 | $0.00 |
| 90674 | 18 | 16 | $0.00 | |
| 83540 | 810 | 604 | $0.00 | |
| 83970 | 535 | 417 | $0.00 | |
| 85048 | 583 | 457 | $0.00 | |
| 85041 | 587 | 460 | $0.00 | |
| 82108 | 57 | 43 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 263 | 39 | $0.00 |
| 85045 | 17 | 15 | $0.00 |